Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Oxazolidinone, 3-(1-oxooctyl)-4-(phenylmethyl)-, (4S)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

152899-13-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 152899-13-3 Structure
  • Basic information

    1. Product Name: 2-Oxazolidinone, 3-(1-oxooctyl)-4-(phenylmethyl)-, (4S)-
    2. Synonyms:
    3. CAS NO:152899-13-3
    4. Molecular Formula: C18H25NO3
    5. Molecular Weight: 303.401
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 152899-13-3.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-Oxazolidinone, 3-(1-oxooctyl)-4-(phenylmethyl)-, (4S)-(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-Oxazolidinone, 3-(1-oxooctyl)-4-(phenylmethyl)-, (4S)-(152899-13-3)
    11. EPA Substance Registry System: 2-Oxazolidinone, 3-(1-oxooctyl)-4-(phenylmethyl)-, (4S)-(152899-13-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 152899-13-3(Hazardous Substances Data)

152899-13-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 152899-13-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,8,9 and 9 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 152899-13:
(8*1)+(7*5)+(6*2)+(5*8)+(4*9)+(3*9)+(2*1)+(1*3)=163
163 % 10 = 3
So 152899-13-3 is a valid CAS Registry Number.

152899-13-3Relevant articles and documents

Understanding Programming of Fungal Iterative Polyketide Synthases: The Biochemical Basis for Regioselectivity by the Methyltransferase Domain in the Lovastatin Megasynthase

Cacho, Ralph A.,Thuss, Justin,Xu, Wei,Sanichar, Randy,Gao, Zhizeng,Nguyen, Allison,Vederas, John C.,Tang, Yi

, p. 15688 - 15691 (2015)

Highly reducing polyketide synthases (HR-PKSs) from fungi synthesize complex natural products using a single set of domains in a highly programmed, iterative fashion. The most enigmatic feature of HR-PKSs is how tailoring domains function selectively during different iterations of chain elongation to afford structural diversity. Using the lovastatin nonaketide synthase LovB as a model system and a variety of acyl substrates, we characterized the substrate specificity of the LovB methyltransferase (MT) domain. We showed that, while the MT domain displays methylation activity toward different β-ketoacyl groups, it is exceptionally selective toward its naturally programmed β-keto-dienyltetraketide substrate with respect to both chain length and functionalization. Accompanying characterization of the ketoreductase (KR) domain displays broader substrate specificity toward different β-ketoacyl groups. Our studies indicate that selective modifications by tailoring domains, such as the MTs, are achieved by higher kinetic efficiency on a particular substrate relative to the rate of transformation by other competing domains.

Synthesis of Rhamnolipid Derivatives Containing Ester Isosteres

Lowary, Todd L.,Wang, Lei

, p. 9633 - 9637 (2020)

Rhamnolipids are biosurfactants with many applications, arising from their inherent biological activity and their potential as bioremediation agents. Herein, we report the synthesis of four rhamnolipid derivatives in which the ester linkage connecting the

Structural Requirements of HDAC Inhibitors: SAHA Analogues Modified at the C2 Position Display HDAC6/8 Selectivity

Negmeldin, Ahmed T.,Padige, Geetha,Bieliauskas, Anton V.,Pflum, Mary Kay H.

supporting information, p. 281 - 286 (2017/03/17)

Histone deacetylase (HDAC) proteins are epigenetic regulators that deacetylate protein substrates, leading to subsequent changes in cell function. HDAC proteins are implicated in cancers, and several HDAC inhibitors have been approved by the FDA as antica

Volatile methyl esters of medium chain length from the bacterium Chitinophaga Fx7914

Nawrath, Thorben,Gerth, Klaus,Mueller, Rolf,Schulz, Stefan

experimental part, p. 2228 - 2253 (2011/05/17)

The analysis of the volatiles released by the novel bacterial isolate Chitinophaga Fx7914 revealed the presence of ca. 200 compounds including different methyl esters. These esters comprise monomethyl- and dimethyl-branched, saturated, and unsaturated fatty acid methyl esters that have not been described as bacterial volatiles before. More than 30 esters of medium C-chain length were identified, which belong to five main classes, methyl (S)-2-methylalkanoates (class A), methyl (S)-2,(ω-1)-dimethylalkanoates (class B), methyl 2,(ω-2)-dimethylalkanoates (class C), methyl (E)-2-methylalk-2-enoates (class D), and methyl (E)-2,(ω-1)-dimethylalk-2- enoates (class E). The structures of the compounds were verified by GC/MS analysis and synthesis of the target compounds as methyl (S)-2-methyloctanoate (28), methyl (S)-2,7-dimethyloctanoate ((S)-43), methyl 2,6-dimethyloctanoate (49), methyl (E)-2-methylnon-2-enoate (20a), and methyl (E)-2,7-dimethyloct-2- enoate (41a). Furthermore, the natural saturated 2-methyl-branched methyl esters showed (S)-configuration as confirmed by GC/MS experiments using chiral phases. Additionally, the biosynthetic pathway leading to the methyl esters was investigated by feeding experiments with labeled precursors. The Me group at C(2) is introduced by propanoate incorporation, while the methyl ester is formed from the respective carboxylic acid by a methyltransferase using S-adenosylmethionine (SAM).

Total synthesis of emericellamides A and B

Li, Shuo,Liang, Shuo,Tan, Wenfei,Xu, Zhengshuang,Ye, Tao

experimental part, p. 2695 - 2702 (2009/06/28)

The total synthesis of emericellamides A and B is reported. A convergent, flexible strategy employing peptide chemistry, asymmetric alkylations, and culminating in macrolactamization is described. The previously reported structure of both compounds is confirmed.

Isolation and total synthesis of gymnastatin N, a POLO-like kinase 1 active constituent from the fungus Arachniotus punctatus

Phoon, Chee Wee,Somanadhan, Brinda,Heng, Sabrina Cher Hui,Ngo, Anna,Ng, Siew Bee,Butler, Mark S.,Buss, Antony D.,Sim, Mui Mui

, p. 11619 - 11628 (2007/10/03)

A high throughput screen against POLO-like kinase 1 (Plk1), an anti-cancer target, identified an active extract from the fungus Arachniotus punctatus. Bioassay guided fractionation led to the isolation of the new natural product, gymnastatin N (1) and the known compound aranorosinol A (2) with IC50 values of 13 and 118 μM, respectively. A 12′-hydroxy analog of gymnastatin N, 3, was also isolated as a minor component. Gymnastatin N (1) was found to be a 52:48 mixture of (1S,6′R) and (1R,6′R) diastereomers, by synthesis of the four possible diastereomers and comparison of the optical rotation and chiral HPLC profile of each diastereoisomer with the natural product. Analogues of 1 were synthesized and evaluated against the Plk1 assay and these SAR studies suggested that the diene and free carboxylic acid moieties might be responsible for its bioactivity. Graphical Abstract.

An efficient strategy for the synthesis of chiral liquid crystals using Evans' methodology

Merlo, Aloir A.,Fernandes, Mirele S.

, p. 1167 - 1178 (2007/10/03)

The synthesis of liquid crystal compound 2 was achieved using Evans' methodology. The strategy was based on three key synthetic reactions: alkylation of chiral amide enolates, Mitsunobu and, finally, esterification. The final compound presents a stable smectic A phase.

Matrix metalloproteinase inhibitors: A structure-activity study

Levy, Daniel E.,Lapierre, France,Liang, Weisheng,Ye, Wenqing,Lange, Christopher W.,Li, Xiaoyuan,Grobelny, Damian,Casabonne, Marie,Tyrrell, David,Holme, Kevin,Nadzan, Alex,Galardy, Richard E.

, p. 199 - 223 (2007/10/03)

Modifications around the dipeptide-mimetic core of a hydroxamic acid based matrix metalloproteinase inhibitor were studied. These variations incorporated a variety of natural, unnatural, and synthetic amino acids inaddition to modifications of the P1' and P3' substituents. The results of this study indicate the following structural requirements: (2) Potent inhibitorsmust possess string zinc-binding functionalities. (3) The potential importance of the hydrophobic group at position R3 as illustratedby itsability to impart greater relative potency against stromelysin when larger hydrophobic groups are used. (4) Requirements surrounding the nature of the amino acid appear to be more restrictive for stromelysin than for neutrophil collagenase, 72 kDa gelatinase, and 92 kDa gelatinase. These requirements may involve planar fused-ring aryl systems and possibly hydrogen-bonding capabilities.

Inhibition of matrix metalloproteinases: An examination of the S1' pocket

Miller, Andrew,Askew, Marion,Beckett, R. Paul,Bellamy, Claire L.,Bone, Elisabeth A.,Coates, Rachael E.,Davidson, Alan H.,Drummond, Alan H.,Huxley, Philip,Martin, Fionna M.,Saroglou, Lydia,Thompson, Alison J.,Van Dijk, Sonja E.,Whittaker, Mark

, p. 193 - 198 (2007/10/03)

Peptidomimetic carboxylate- and hydroxamate-based inhibitors of matrix metalloproteinases containing extended P1' groups have been prepared. Potent inhibition and good selectivity for MMP-2 has been observed for the compounds produced.

The total synthesis of the diepoxycyclohexanone antibiotic aranorosin and novel synthetic analogues

McKillop, Alexander,McLaren, Lee,Taylor, Richard J. K.,Watson, Robert J.,Lewis, Norman J.

, p. 1385 - 1393 (2007/10/03)

A short synthesis of the novel antibiotic aranorosin in chiral form is described which employs (i) a novel hypervalent iodine-mediated oxidative hydroxylation of a tyrosinal derivative and (ii) a stereocontrolled cis-bisepoxidation in the key steps. A similar procedure was employed to prepare 6′-epiaranorosin, and hence establish the stereochemistry of the natural compound, and to prepare novel aranorosin analogues. An organometallic route is described which gives desamidoaranorosin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 152899-13-3